Lucid Diagnostics Inc.
LUCD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 79% | 544% | -24.6% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -90.2% | -249.2% | -858.6% | -17% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,020.2% | -2,049.1% | -14,385.9% | -5,483% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,047.6% | -2,169.1% | -14,899.5% | -5,615.6% |
| EPS Diluted | -1.05 | -1.26 | -1.55 | -0.78 |
| % Growth | 16.7% | 18.7% | -98.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |